A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01513863. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Compare the Bioequivalence of Two Metronidazole 1% Topical Gel Formulations in Patients With Moderate to Severe Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to demonstrate that metronidazole 1% topical gel is effective for the treatment of patients with moderate to severe rosacea.
Study identification
- NCT ID
- NCT01513863
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 602 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2011 (Type not available)
- Primary completion
- Jun 2012 (Actual)
- Completion
- Sep 2012 (Actual)
- Last update posted
- Dec 23, 2013
2011 – 2012
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site | Phoenix | Arizona | — | — |
| Investigator Site | Long Beach | California | — | — |
| Investigator Site | Newport Beach | California | — | — |
| Investigator Site | Denver | Colorado | — | — |
| Investigator Site | Jacksonville | Florida | — | — |
| Investigator Site | Miami | Florida | — | — |
| Investigator Site | Miramar | Florida | — | — |
| Investigator Site | Arlington Heights | Illinois | — | — |
| Investigator Site | Plainfield | Indiana | — | — |
| Investigator Site | Henderson | Nevada | — | — |
| Investigator Site | Hickory | North Carolina | — | — |
| Investigator Site | High Point | North Carolina | — | — |
| Investigator Site | Wilmington | North Carolina | — | — |
| Investigator Site | South Euclid | Ohio | — | — |
| Investigator Site | Hazleton | Pennsylvania | — | — |
| Investigator Site | Simpsonville | South Carolina | — | — |
| Investigator Site | Kingsport | Tennessee | — | — |
| Investigator Site | Knoxville | Tennessee | — | — |
| Investigator Site | Nashville | Tennessee | — | — |
| Investigator Site | San Antonio | Texas | — | — |
| Investigator Site | Webster | Texas | — | — |
| Investigator Site | West Jordan | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01513863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2013 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.